Zobrazeno 1 - 7
of 7
pro vyhledávání: '"John Kauh"'
Publikováno v:
PLoS ONE, Vol 5, Iss 4, p e10376 (2010)
Great efforts have been made to develop novel and efficacious therapeutics against pancreatic cancer to improve the treatment outcomes. Tumor-necrosis factor-related apoptosis-inducing ligand (TRAIL) is such a therapeutic cytokine with selective kill
Externí odkaz:
https://doaj.org/article/2e977a72b61349848a19cc7a6fbe2b89
Autor:
Sujana Movva, Alexander I. Spira, Erika P. Hamilton, Judy S. Wang, Allen Lee Cohn, James F. Strauss, Silvia Stacchiotti, Chris Tucci, John Kauh, Shivani Nanda, Marek K. Kania, Shreyaskumar Patel
Publikováno v:
Journal of Clinical Oncology. 40:11557-11557
11557 Background: Surufatinib is an inhibitor of VEGFR1, 2, & 3, FGFR1, and CSF-1R. A manageable safety profile, and statistically significant improvement in progression-free survival (PFS) in patients (pts) treated with surufatinib have previously b
Autor:
Walid L, Shaib, Rahul, Sharma, Edith, Brutcher, Sungjin, Kim, Shishir K, Maithel, Zhengjia, Chen, David A, Kooby, John, Kauh, Jerome, Landry, Bassel F, El-Rayes
Publikováno v:
Journal of surgical oncology. 109(6)
Ampullary (AMP-A) and duodenal adenocarcinomas (DA) are rare tumors. The literature regarding treatment and outcome is very limited. The objective of this project is to compare the outcomes of AMP-A and DA.The records for AMP-A and DA patients betwee
Autor:
William A, Hall, Lauren E, Colbert, Yuan, Liu, Theresa, Gillespie, Joseph, Lipscomb, Claire, Hardy, David A, Kooby, Roshan S, Prabhu, John, Kauh, Jerome C, Landry
Publikováno v:
Cancer. 119(12)
Adjuvant radiotherapy (A-RT) for patients with resected pancreatic adenocarcinoma (PAC) is controversial. In the current study, the authors aim to determine whether there is an association between overall survival (OS) and A-RT dose.National Cancer D
Autor:
John, Kauh, Mary, Koshy, Clifford, Gunthel, Melissa M, Joyner, Jerome, Landry, Charles R, Thomas
Publikováno v:
Oncology (Williston Park, N.Y.). 19(12)
Squamous cell anal cancer remains an uncommon entity; however, the incidence appears to be increasing in at-risk populations, especially those infected with human papillomavirus (HPV) and human immunodeficiency virus (HIV). Given the ability to cure
Autor:
John L, Marshall, Naiyer, Rizvi, John, Kauh, William, Dahut, Manuela, Figuera, Min H, Kang, William D, Figg, Irving, Wainer, Christoff, Chaissang, Megan Zhaoyang, Li, Michael J, Hawkins
Publikováno v:
Journal of experimental therapeuticsoncology. 2(6)
Depsipeptide (FR901228) is a bicyclic peptide isolated from Chromobacterium violaceum that has demonstrated potent in vitro cytotoxic activity against human tumor cell lines and in vivo efficacy against human tumor xenografts. The primary mechanism o
Autor:
John Kauh
Publikováno v:
Journal of Surgical Oncology; May2005, Vol. 90 Issue 2, p106-107, 2p